![Mark Beveridge](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Beveridge
Financieel Directeur/CFO bij
MOBERG PHARMA AB
Profiel
Mark Beveridge currently works at Biosergen AB, as Chief Financial Officer from 2025 and Moberg Pharma AB, as Vice President-Finance from 2015.
Mr. Beveridge also formerly worked at OncoZenge AB, as Chief Financial Officer.
Mr. Beveridge received his undergraduate degree from the University of Western Sydney.
Actieve functies van Mark Beveridge
| Bedrijven | Functie | Begin |
|---|---|---|
| MOBERG PHARMA AB | Financieel Directeur/CFO | 01-01-2015 |
| BIOSERGEN AB | Financieel Directeur/CFO | 24-07-2025 |
Eerdere bekende functies van Mark Beveridge
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOZENGE AB | Financieel Directeur/CFO | - |
Opleiding van Mark Beveridge
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
47
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Western Sydney
 University of Western Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moberg Pharma AB
 Moberg Pharma AB Pharmaceuticals: MajorHealth Technology Develops and commercializes medical products | Health Technology |
OncoZenge AB
 OncoZenge AB Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops products for supportive care of cancer patients | Health Technology |
Biosergen AB
 Biosergen AB BiotechnologyHealth Technology Operates as a biotechnology company that develops antifungal drugs | Health Technology |
